ロード中...
Rosiglitazone activation of PPARγ suppresses fractalkine signaling
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a key transcriptional regulator of both lipid metabolism and inflammation. The importance of PPARγ is accentuated by the widespread use of synthetic PPARγ agonists, thiazolidinediones (such as rosiglitazone), as drugs for i...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society for Endocrinology
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2805405/ https://ncbi.nlm.nih.gov/pubmed/19850645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/JME-09-0090 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|